Gender differences in post-operative pain and patient controlled analgesia use among adolescent surgical patients

Pain ◽  
2004 ◽  
Vol 109 (3) ◽  
pp. 481-487
Author(s):  
D LOGAN
2009 ◽  
Vol 5 ◽  
pp. 1744-8069-5-32 ◽  
Author(s):  
Ene-choo Tan ◽  
Eileen CP Lim ◽  
Yik-ying Teo ◽  
Yvonne Lim ◽  
Hai-yang Law ◽  
...  

2007 ◽  
Vol 35 (4) ◽  
pp. 497-507 ◽  
Author(s):  
YY Lee ◽  
KH Kim ◽  
YH Yom

This study identified predictive factors for post-operative nausea and vomiting (PONV) in patients using patient-controlled analgesia (PCA) and developed five predictive model pathways to calculate the probability of PONV using decision tree analysis. The sample consisted of 1181 patients using PCA. Data were collected using: a specifically designed check-off form to collect patient-, surgery-, anaesthesia- and post-operation-related data; the Beck Anxiety Inventory® to measure pre-operative anxiety; and a visual analogue scale, to measure post-operative pain. The incidence of PONV was 27.7%. Nine factors were highly predictive of PONV in our five model pathways: gender, obesity, anxiety, history of previous PONV, history of motion sickness, inhalation of nitrous oxide during operation, use of inhalational agents, starting oral fluid/food intake after operation, and post-operative pain. With these five predictive model pathways, we can predict the probability of PONV in an individual patient according to their individual characteristics.


1973 ◽  
Vol 1 (2) ◽  
pp. 422-428
Author(s):  
Robert E S Young

A double-blind, randomized trial was conducted in 120 post-surgical patients to evaluate the oral analgesic activity of butorphanol tartrate (4 mg and 8 mg) and pentazocine HCl (50 mg) as compared to placebo. Both doses of butorphanol as well as pentazocine proved to be significantly (p <0.05) more effective than placebo. Butorphanol 4 mg and pentazocine 50 mg were never significantly different from each other, while butorphanol 8 mg was significantly better than both butorphanol 4 mg as well as pentazocine 50 mg in several instances, demonstrating a significant dose effect relationship for butorphanol. All of the active treatments provided maximum pain relief within 1 to 2 hours and were effective over 4 hours. In contrast to the other treatments, none of the 8 mg butorphanol patients required remedication during the 4-hour observation period. Generally, the incidence of side-effects appeared low.


Sign in / Sign up

Export Citation Format

Share Document